Glycogen storage disease type II screening: Difference between revisions
Irfan Dotani (talk | contribs) (Created page with "__NOTOC__ {{Glycogen storage disease type II}} {{CMG}}; {{AE}} {{PleaseHelp}} ==Overview== ==Screening== ==References== {{reflist|2}} Category:Endocrinology Categor...") |
No edit summary |
||
Line 3: | Line 3: | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} | ||
==Overview== | |||
There is insufficient evidence to recommend routine screening for [disease/malignancy]. | |||
OR | |||
According to the [guideline name], screening for [disease name] is not recommended. | |||
OR | |||
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3]. | |||
==Screening== | ==Screening== | ||
*There is insufficient evidence to recommend routine screening for [disease/malignancy]. | |||
OR | |||
*According to the [guideline name], screening for [disease name] is not recommended. | |||
OR | |||
*According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with: | |||
**[Condition 1] | |||
**[Condition 2] | |||
**[Condition 3] | |||
==References== | ==References== |
Revision as of 16:18, 5 January 2018
Glycogen storage disease type II Microchapters |
Differentiating Glycogen storage disease type II from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Glycogen storage disease type II screening On the Web |
American Roentgen Ray Society Images of Glycogen storage disease type II screening |
Directions to Hospitals Treating Glycogen storage disease type II |
Risk calculators and risk factors for Glycogen storage disease type II screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
Screening
- There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
- According to the [guideline name], screening for [disease name] is not recommended.
OR
- According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with:
- [Condition 1]
- [Condition 2]
- [Condition 3]